British Journal of Pharmacology

Papers
(The H4-Index of British Journal of Pharmacology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Issue Information477
363
Issue Information280
277
Issue Information185
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”170
157
Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors152
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR151
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries132
132
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice131
Exploring pharmacological inhibition of Gq/11 as an analgesic strategy100
A new class of 5‐HT2A/5‐HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins98
Chemosensory signalling in human sperm is controlled by Ca2+ influx via CatSper and Ca2+ clearance via plasma membrane Ca2+ ATPases97
EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type‐1 Diabetic Mice93
Correction to ‘Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy’92
Biphasic effect of nicotine on glutamatergic activity in male mouse brain88
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer86
The potential for biased signalling in the P2Y receptor family of GPCRs75
Novel therapeutic approaches to target neurodegeneration72
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction67
P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity67
6‴‐Feruloylspinosin ameliorates pressure overload‐induced heart failure with comorbid insomnia through the activation of RORα64
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin59
Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis58
Clinical‐data‐driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma57
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice52
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs51
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review51
The fast‐dissociating D2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment50
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis49
Opportunities of patient‐derived organoids in drug development49
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline48
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer47
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine46
Supersulfide biology and translational medicine for disease control46
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning45
GPR84 in physiology—Many functions in many tissues44
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury43
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors41
Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model41
0.19027996063232